| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 122 |
| 1 | METHOTREXATE SODIUM | 54 |
| 2 | OMEPRAZOLE MAGNESIUM | 51 |
| 3 | METHOTREXATE | 48 |
| 4 | ASPIRIN | 47 |
| 5 | INFLIXIMAB | 46 |
| 6 | ASPIRIN 325 MG | 45 |
| 7 | ASPIRIN 81 MG | 45 |
| 8 | FUROSEMIDE | 43 |
| 9 | OMEPRAZOLE | 36 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 4 | 0.0377 |
| 1 | MEPIVACAINE HYDROCHLORIDE | 9 | 0.0078 |
| 2 | BEZLOTOXUMAB | 2 | 0.0057 |
| 3 | SEROTONIN | 1 | 0.0037 |
| 4 | PANTHENOL | 1 | 0.0034 |
| 5 | POTASSIUM IODIDE | 4 | 0.0027 |
| 6 | TRIMIPRAMINE MALEATE | 1 | 0.0025 |
| 7 | VERAPAMIL HYDROCHLORIDE | 9 | 0.0021 |
| 8 | IMIPRAMINE HYDROCHLORIDE | 1 | 0.0018 |
| 9 | XYLOMETAZOLINE HYDROCHLORIDE | 1 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 96 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 84 |
| 2 | Corticosteroid [EPC] | 71 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 48 |
| 4 | Proton Pump Inhibitor [EPC] | 48 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 47 |
| 6 | Factor Xa Inhibitor [EPC] | 43 |
| 7 | Loop Diuretic [EPC] | 43 |
| 8 | Kinase Inhibitor [EPC] | 41 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 40 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 2 | CD19-directed Chimeric Antigen Receptor [EPC] | 10 | 0.0010 |
| 3 | Calcitonin [EPC] | 2 | 0.0006 |
| 4 | Provitamin D2 Compound [EPC] | 19 | 0.0006 |
| 5 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 7 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 2 | 0.0005 |
| 8 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 9 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |